XBiotech XBIT
NASDAQ XBIT
$2.18 +0.03 (+1.40%)
At close: Sep 29, 2026 · 4:00 PM EDT

XBiotech (XBIT) Receivables - Accured (2022 - 2026)

Updated

XBiotech (XBIT) reported Receivables - Accured of $277,000 for Q2 2026.

Analysis

XBiotech (XBIT) Receivables - Accured (2022 - 2026) Analysis & Trends

At the end of FY2025, XBiotech posted Receivables - Accured of $360,000, down 48.6% from FY2024.

  • Receivables - Accured has declined for three consecutive years, with a three-year compound annual growth rate of -33.4% (FY2022 to FY2025).
  • By year, Receivables - Accured came in at $700,000 in FY2024 (-18.6%), $860,000 in FY2023 (-29.3%) and $1.22 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 XBiotech 65.55 Mn 65.55 Mn - 277,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 277,000.00
Dec 31, 2025 360,000.00
Dec 31, 2024 700,000.00
Dec 31, 2023 860,000.00
Jun 30, 2023 3.22 Mn
Mar 31, 2023 2.37 Mn
Dec 31, 2022 1.22 Mn
API Access

XBiotech Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=XBIT&period=max&api_key=YOUR_API_KEY